Partnering with Eisai
Why We Partner
While Eisai is a fully integrated pharmaceutical business capable of discovering, developing, manufacturing, marketing and distributing products on its own, we also recognize the value of collaboration. Eisai believes that its human health care mission of helping to increase the benefits that health care provides to patients and their families can be advanced through collaboration with other companies that share our goal of helping to address unmet medical needs.
Working with Eisai
Eisai takes a strategic approach to business development activities, ensuring that the expectations of our partners are aligned with our own. We are an experienced and flexible partner that will work diligently to maximize the success of our partners’ compounds.
We have a proven track record with a variety of partnerships and collaborations, including strategic copromotions and research collaborations, and we are interested in pursuing opportunities in a variety of therapeutic areas. Eisai offers its partners strong Research & Discovery (R&D) and commercial resources as well as the experience needed to guide products through the regulatory process.
We invite academic institutions and pharmaceutical or biotech companies that share our goal of helping to address unmet medical needs to contact us with proposals.
Also across worldwide, Eisai has a number of research collaborations with biotech firms and academic institutions. These include agreements with other laboratories like Biogen and MSD with the aim of discover and develop novel treatment through innovative new products and synergic combinations in some cases.
Investigator Initiated Studies (IIS)
Eisai’s Investigator Initiated Studies (IIS) Program provides funding and/or clinical supplies to eligible applicants to help address legitimate medical or scientific questions affecting the use of Eisai marketed products or investigational compounds.